/Companies

Grandomics

Beijing, CN · 3 known investors

Find your way into Grandomics

Sign up to see every warm intro you have to Grandomics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Grandomics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Grandomics develops third-generation sequencing services and precision genomic medicine solutions for medical diagnostics, plant and animal breeding, and species conservation. The company applies long-read sequencing technology and computational methods to assemble complete genomes and address applications in medicine, crop improvement, and biodiversity protection.

Founders & leadership

汪
汪德鹏CEO and Head of Technology Services BU
王
王洋Executive Vice President and Chief Sequencing Technology Officer
赵
赵云龙Chief Operating Officer

Investors · 3

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Grandomics do?
Grandomics develops third-generation sequencing services and precision genomic medicine solutions for medical diagnostics, plant and animal breeding, and species conservation. The company applies long-read sequencing technology and computational methods to assemble complete genomes and address applications in medicine, crop improvement, and biodiversity protection.
Who are Grandomics's investors?
Grandomics's investors include Matrix Partners China, Vitalbridge Capital, Marathon Venture Partners.
Where is Grandomics headquartered?
Grandomics is headquartered in Beijing, CN.